TransCode Therapeutics Inc (NASDAQ: RNAZ) is -90.91% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $20.69 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RNAZ stock was last observed hovering at around $0.68 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $0.60, the stock is 4.67% and 53.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.96 million and changing -11.80% at the moment leaves the stock -34.30% off its SMA200. RNAZ registered -96.60% loss for a year compared to 6-month loss of 19.32%. The firm has a 50-day simple moving average (SMA 50) of $0.391 and a 200-day simple moving average (SMA200) of $0.91174.
The stock witnessed a 71.14% gain in the last 1 month and extending the period to 3 months gives it a -27.74%, and is -17.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.23% over the week and 26.77% over the month.
TransCode Therapeutics Inc (RNAZ) has around 10 employees, a market worth around $10.34M and $0.00M in sales. Distance from 52-week low is 177.31% and -97.10% from its 52-week high. The company has generated returns on investments over the last 12 months (-1354.12%).
The EPS is expected to grow by 98.01% this year
17.0 institutions hold shares in TransCode Therapeutics Inc (RNAZ), with institutional investors hold 11.47% of the company’s shares. The shares outstanding are 17.27M, and float is at 17.23M with Short Float at 8.03%. Institutions hold 11.46% of the Float.
